Blue Water Vaccines appoints head of science and discovery

Blue Water Vaccines appoints head of science and discovery

Blue Water Vaccines Inc., a biopharmaceutical company, has made Dr. Ronald R. Cobb its head of Science and Discovery.
“We welcome Ron as an expert strategist with deep knowledge of developing early-stage drugs into successful assets,” says Joseph Hernandez, chairman and CEO of Blue Water Vaccines. “We look forward to him leading Blue Water Vaccines’ pipeline initiatives, which focus on treating and preventing pathogen infections.”

“I am excited to join the growing team at Blue Water Vaccines and to be involved in the critical process of bringing life-saving vaccines to patients globally,” Dr. Cobb says. “Pathogenic infections like Influenza, Streptococcus pneumoniae, and the norovirus are profound global issues that demand effective solutions. As the head of Blue Water Vaccines’ scientific initiatives, I plan to propel these ongoing programs forward and establish their clinical path.”

Dr. Ron Cobb is a geneticist and a molecular biologist with over 25 years of pharmaceutical R&D and manufacturing experience. In his previous roles, Dr. Cobb was responsible for various leadership positions. He was most recently the chief scientific officer at Ology Bioservices.